Abstract:MicroRNAs (miRNAs) are small, single-stranded, noncoding RNAs that can post-transcriptionally regulate the expression of various oncogenes and tumor suppressor genes. Dysregulated expression of many miRNAs have been shown to mediate the signaling pathways critical in the multistep carcinogenesis of colorectal cancer (CRC). MiRNAs are stable and protected from RNase-mediated degradation, thereby enabling its detection in biological fluids and archival tissues for biomarker studies. This review focuses on the role and application of miRNAs in the prognosis and therapy of CRC. While stage II CRC is potentially curable by surgical resection, a significant percentage of stage II CRC patients do develop recurrence. MiRNA biomarkers may be used to stratify such high-risk population for adjuvant chemotherapy to provide better prognoses. Growing evidence also suggests that miRNAs are involved in the metastatic process of CRC. Certain of these miRNAs may thus be used as prognostic biomarkers to identify patients more likely to have micro-metastasis, who could be monitored more closely after surgery and/or given more aggressive adjuvant chemotherapy. Intrinsic and acquired resistance to chemotherapy severely hinders successful chemotherapy in CRC treatment. Predictive miRNA biomarkers for response to chemotherapy may identify patients who will benefit the most from a particular regimen and also spare the patients from unnecessary side effects. Selection of patients to receive the new targeted therapy is becoming possible with the use of predictive miRNA biomarkers. Lastly, forced expression of tumor suppressor miRNA or silencing of oncogenic miRNA in tumors by gene therapy can also be adopted to treat CRC alone or in combination with other chemotherapeutic drugs.

Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells

MicroRNA as regulators of cancer stem cells and chemoresistance in colorectal cancer.

MicroRNAs and colorectal cancer: clinical potential and regulatory networks

&Lt;p>micrornas: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications</p>

MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer

MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications

Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer

Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome

MicroRNAs in colorectal cancer: Small molecules with big functions

MicroRNAs As Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer

MicroRNAs in colorectal carcinoma--from pathogenesis to therapy

microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities

Expression Profile, Molecular Functions, and Prognostic Significance of Mirnas in Primary Colorectal Cancer Stem Cells

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

MicroRNA Regulation of Liver Cancer Stem Cells.

Mir‐372 and Mir‐373 Enhance the Stemness of Colorectal Cancer Cells by Repressing Differentiation Signaling Pathways

The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review

Screening and introduction of key cell cycle microRNAs deregulated in colorectal cancer by integrated bioinformatics analysis